EQS-AFR: Heidelberg Pharma AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]


Werte in diesem Artikel
Aktien

2.60 EUR 0.04 EUR 1.56 %

EQS Preliminary announcement financial reports: Heidelberg Pharma AG / Preliminary announcement on the disclosure of financial statements
Heidelberg Pharma AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

11.03.2026 / 09:16 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

Werbung


Heidelberg Pharma AG hereby announces that the following financial reports shall be disclosed:

Report Type: Annual financial report

Language: German
Date of disclosure: March 26, 2026
Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte

Language: English
Date of disclosure: March 26, 2026
Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports

Report Type: Financial report (half-year/Q2)

Language: German
Date of disclosure: July 15, 2026
Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte

Language: English
Date of disclosure: July 15, 2026
Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports

Report Type: Annual financial report of the group

Language: German
Date of disclosure: March 26, 2026
Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte

Language: English
Date of disclosure: March 26, 2026
Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports

Report Type: Financial report of the group (half-year/Q2)

Language: German
Date of disclosure: July 15, 2026
Address: https://heidelberg-pharma.com/de/presse-investoren/mitteilungen-und-berichte/finanzberichte

Language: English
Date of disclosure: July 15, 2026
Address: https://heidelberg-pharma.com/en/press-investors/announcements/financial-reports


11.03.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language: English
Company: Heidelberg Pharma AG
Gregor-Mendel-Str. 22
68526 Ladenburg
Germany
Internet: www.heidelberg-pharma.com

 
End of News EQS News Service

Werbung

2289262  11.03.2026 CET/CEST

Aktuelle Heidelberg Pharma Aktie News

Werbung

Heidelberg Pharma Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Heidelberg Pharma nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
27.02.13 WILEX kaufen equinet
23.01.13 WILEX kaufen equinet AG
19.06.12 WILEX buy WestLB AG
19.10.11 WILEX buy WestLB AG
17.06.10 WILEX Stoppkurs 6,90 EUR Focus Money